Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus

NAActive, not recruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

January 24, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

January 31, 2026

Conditions
Type 2 Diabetes
Interventions
BEHAVIORAL

Intermittent energy restriction (IER)

During Phase 1 (Weight Loss), participants will follow a very-low energy diet (VLED; 550-800 kcal/d) 2-3 days per week. On other days, participants do not have a specific kcal goal (non-fasting days). After Phase 1, IER participants will be instructed to follow a VLED 1-2 days per week as needed for weight maintenance.

BEHAVIORAL

Time Restricted Eating (TRE)

Participants will eat within an 8-hour period most days (at least 5 days per week). All foods and beverages containing calories will be restricted to this 8-hour period but calorie-free beverages (coffee, tea, diet soda, etc.) are allowed at any time. TRE participants will follow healthy eating guidelines for weight loss during Phase 1 but not follow a specific kcal prescription or restrict intake thereafter.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

University of Kansas Medical Center

OTHER